cas 107504-07-4|| where to buy Methyl 5-fluoropyridine-2-carboxylate

Nom du produit:Methyl 5-fluoropyridine-2-carboxylate

IUPAC Name:methyl 5-fluoropyridine-2-carboxylate

Unité d'emballage	Stock disponible	Prix($)
CM176763-10g	in stock	Ȁǯŭ
CM176763-25g	in stock	Ŕňň
CM176763-100g	in stock	ŭƅƻ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 107504-07-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:107504-07-4; Formule moléculaire:C7H6FNO2; Point de fusion:-; Code SMILES:O=C(OC)C1=NC=C(F)C=C1; Densité:

: Numéro de catalogue:CM176763; Poids moléculaire:155.13; Point d'ébullition:; N° Mdl:MFCD11845630; Stockage:Store at 2-8°C.

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: NX-5948; Nurix announced the presentation of the first findings of clinical responses in the brain for NX-5948. NX-5948 is an investigational, orally bioavailable, brain penetrant, small molecule degrader of BTK. NX-5948 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory B cell malignancies.